Effects of Hedysari Radix Flavonoids in Different Time Points on Angiogenesis Index in Pulmonary Interstitial Fibrosis Rat Model

LI Juan; SU Yun; ZHANG Yi; LIU Yong-qi; SHE Ya-li; CHENG Xiao-li; LI Jin-tian

doi:10.11653/syfj2014030129

您当前的位置：

首页 >

文章列表页 >

Effects of Hedysari Radix Flavonoids in Different Time Points on Angiogenesis Index in Pulmonary Interstitial Fibrosis Rat Model

更新时间：2024-01-04

- Effects of Hedysari Radix Flavonoids in Different Time Points on Angiogenesis Index in Pulmonary Interstitial Fibrosis Rat Model
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 3, Pages: 129-132(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2014030129
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
LI Juan, SU Yun, ZHANG Yi, et al. Effects of Hedysari Radix Flavonoids in Different Time Points on Angiogenesis Index in Pulmonary Interstitial Fibrosis Rat Model[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(3): 129-132.
DOI：

LI Juan, SU Yun, ZHANG Yi, et al. Effects of Hedysari Radix Flavonoids in Different Time Points on Angiogenesis Index in Pulmonary Interstitial Fibrosis Rat Model[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(3): 129-132. DOI： 10.11653/syfj2014030129.

摘要

目的：探讨红芪黄酮在不同时间点对肺间质纤维化模型大鼠微血管新生指标的影响。方法： SPF级Wistar大鼠144只，分为空白组、模型组、强的松组、红芪黄酮高、中、低剂量组，采用博莱霉素气管滴入方法建立肺纤维化模型，从造模后第2天起，各药物组分别给予相应剂量药物，按时间点连续灌胃治疗14，28 d，免疫组化法观察微血管内皮生长因子（VEGF）及其受体（VEGFR2）表达。结果： 14，28 d模型组大鼠肺组织VEGF，VEGFR2表达较空白组明显增强（P < 0.05， P < 0.01），14 d红芪黄酮高剂量组大鼠肺组织VEGF，VEGFR2表达较14 d模型组减弱（P < 0.05）。28 d红芪黄酮高剂量组VEGF，VEGFR2表达水平较28 d模型组减弱（P < 0.05）。14，28 d红芪黄酮低剂量组VEGF、VEGFR2表达较28 d模型组相近。14，28 d红芪黄酮中剂量组VEGF，VEGFR2表达介于14，28 d高剂量组与低剂量组之间，但与14，28 d模型组相较无统计学意义。结论：红芪黄酮抗纤维化的作用机制可能是通过抑制微血管新生相关促进因子（VEGF及VEGFR2），进而抑制了病理性微血管的生成，而达到了延缓肺纤维化的作用。

Abstract

Objective: To study the effect of Hedysari Radix flavonoids in different time points on angiogenesis index in the pulmonary interstitial fibrosis rat model. Method: Hundred and forty-four SPF Wistar rats were distributed to blank group

model group

prednisone group

Hedysari Radix flavonoids high

middle

low dose groups by bleomycin intratracheal instillation method to establish the model of pulmonary fibrosis. From the second day after modeling

the corresponding drugs were given to each group

ig for 14 days or 28 days. Immunohistochemistry method was used to observe the expression of vascular endothelial growth factor (VEGF) and its receptor (VEGFR2). Result: Model groups 14

28 days VEGF and VEGFR2 increased significantly when compared with the control group.Compared with 14 d model group

high dose flavonoids group in VEGF and VEGFR2 expression decreased (P<0.05). Compared with 28 d model group

high dose flavonoids group in VEGF and VEGFR2 expression decreased significantly (P<0.05). Fourteen

28 d low dose groups had no significant difference with the 28 d model group

in VEGF and VEGFR2 expression. 14

28 d middle dose groups in expression of VEGF and VEGFR2 were between 14

28 d high dose group and low dose group

and had no statistical significance with 14 d

28 d model group. Conclusion: The anti fibrosis mechanism of Hedysari Radix flavonoids was probably through inhibiting angiogenesis related factor VEGF and VEGFR2 to inhibit the formation of pathological angiogenesis resulting in the delayed pulmonary fibrosis.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway

Bufei Tongbi Decoction Inhibits Pulmonary Fibrosis in Diabetic Rats via TGF-β₁/p-Smad3 Signaling Pathway

Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway

Effect of Xiao Xianxiongtang on 5-FU-mediated Myocardial Fibrosis and Protein Expression of HIF-1α/VEGF Signaling Pathway in Mice

Investigating Mechanism of Fritillariae Cirrhosae Bulbus Against Pulmonary Fibrosis Based on Spatial Metabolomics

Related Author

LIU Quan

HE Yiqing

ZHANG Ying

WANG Xi

YANG Shuo

WANG Gang

YUE Rensong

YANG Qiyue

Related Institution

Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Zigong First People's Hospital

MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰